Fostering active choice to empower behavioral change to reduce cardiovascular risk: A web-based randomized controlled trial.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 31 10 2023
accepted: 21 05 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 1 8 2024
Statut: epublish

Résumé

To investigate the effect of an active choice (AC) intervention based on creating risk and choice awareness-versus a passive choice (PC) control group-on intentions and commitment to cardiovascular disease (CVD) risk-reducing behavior. Adults aged 50-70 (n = 743) without CVD history participated in this web-based randomized controlled trial. The AC intervention included presentation of a hypothetical CVD risk in a heart age format, information about CVD risk and choice options, and a values clarification exercise. The PC group received a hypothetical absolute numerical CVD risk and brief information and advice about lifestyle and medication. Key outcomes were reported degree of active choice, intention strength, and commitment to adopt risk-reducing behavior. More AC compared to PC participants opted for lifestyle change (OR = 2.86, 95%CI:1.51;5.44), or lifestyle change and medication use (OR = 2.78, 95%CI:1.42;5.46), than 'no change'. No differences were found for intention strength. AC participants made a more active choice than PC participants (β = 0.09, 95%CI:0.01;0.16), which was sequentially mediated by cognitive risk perception and negative affect. AC participants also reported higher commitment to CVD risk-reducing behavior (β = 0.32, 95%CI:0.04;0.60), mediated by reported degree of active choice. Fostering active choices increased intentions and commitment towards CVD risk-reducing behavior. Increased cognitive risk perception and negative affect were shown to mediate the effect of the intervention on degree of active choice, which in turn mediated the effect on commitment. Future research should determine whether fostering active choice also improves risk-reducing behaviors in individuals at increased CVD risk in real-life settings. ClinicalTrials.gov: NCT05142280. Prospectively registered.

Identifiants

pubmed: 39088470
doi: 10.1371/journal.pone.0304897
pii: PONE-D-23-22195
doi:

Banques de données

ClinicalTrials.gov
['NCT05142280']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0304897

Informations de copyright

Copyright: © 2024 Landais et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exists

Auteurs

Lorraine L Landais (LL)

Department of Public and Occupational Health, Amsterdam UMC, Amsterdam Public Health Research institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Judith G M Jelsma (JGM)

Department of Public and Occupational Health, Amsterdam UMC, Amsterdam Public Health Research institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Olga C Damman (OC)

Department of Public and Occupational Health, Amsterdam UMC, Amsterdam Public Health Research institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Evert A L M Verhagen (EALM)

Department of Public and Occupational Health, Amsterdam UMC, Amsterdam Public Health Research institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Amsterdam Collaboration on Health & Safety in Sports, Department of Public and Occupational Health, Amsterdam Movement Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Danielle R M Timmermans (DRM)

Department of Public and Occupational Health, Amsterdam UMC, Amsterdam Public Health Research institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH